Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)
Titel:
Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)
Auteur:
Donini, M. Buti, S. Lazzarelli, S. Bozzetti, R. Rivoltini, L. Camisaschi, C. Castelli, C. Bearz, A. Simonelli, C. Lo Re, G. Mattioli, R. Caminiti, C. Passalacqua, R.